Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Karan Agrawal, PhD (he/him/his)

Principal Scientist
Johnson & Johnson
Spring House, Pennsylvania

Dr. Karan Agrawal is a Principal Scientist in the Bioanalytical Discovery and Development Sciences team within the Preclinical Sciences and Translational Safety organization at Johnson & Johnson Innovative Medicine in Spring House, Pennsylvania. In this role, Karan focuses on the development and application of LC-MS bioanalytical assays for the quantitative assessment of large and small molecule biomarkers and drug candidates, focusing on novel modalities. Dr. Agrawal also drives innovation at J&J, evaluating new analytical technologies and sample preparation approaches to help answer challenging biological questions.

Prior to joining J&J, Karan was a Staff Scientist at Labcorp Drug Development in Indianapolis, Indiana, where he conducted bioanalytical method development and validation for small and large molecule analytes by LC-MS/MS. Dr. Agrawal earned a B.A. in Chemistry and Molecular Biology from Cornell University, an M.Sc. in Forensic Science from King’s College London, and a Ph.D. in Pharmacology and Toxicology from the University of California-Davis.

Disclosure information not submitted.

Presentation(s):